Susquehanna International Group, LLP Immutep LTD Transaction History
Susquehanna International Group, LLP
- $823 Billion
- Q3 2025
A detailed history of Susquehanna International Group, LLP transactions in Immutep LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 95,254 shares of IMMP stock, worth $177,172. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,254
Previous 58,310
63.36%
Holding current value
$177,172
Previous $95,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding IMMP
# of Institutions
37Shares Held
2.36MCall Options Held
1.42KPut Options Held
20K-
Black Rock Inc. New York, NY839KShares$1.56 Million0.0% of portfolio
-
Meridian Wealth Management, LLC421KShares$782,8740.03% of portfolio
-
Sender CO & Partners, Inc. New York, NY216KShares$401,5010.13% of portfolio
-
Morgan Stanley New York, NY166KShares$308,6960.0% of portfolio
-
Verition Fund Management LLC Greenwich, CT75KShares$139,5000.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $161M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...